Does ARGATROBAN Cause Activated partial thromboplastin time prolonged? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Activated partial thromboplastin time prolonged have been filed in association with ARGATROBAN (Argatroban). This represents 1.9% of all adverse event reports for ARGATROBAN.
13
Reports of Activated partial thromboplastin time prolonged with ARGATROBAN
1.9%
of all ARGATROBAN reports
4
Deaths
6
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From ARGATROBAN?
Of the 13 reports, 4 (30.8%) resulted in death, 6 (46.2%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARGATROBAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ARGATROBAN Cause?
Drug ineffective (109)
Heparin-induced thrombocytopenia (91)
Off label use (55)
Haemorrhage (45)
Cerebral infarction (35)
Disseminated intravascular coagulation (35)
Pulmonary embolism (30)
Deep vein thrombosis (29)
Thrombocytopenia (29)
Thrombosis (25)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which ARGATROBAN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
ARGATROBAN vs ARGININE
ARGATROBAN vs ARGININE\LYSINE
ARGATROBAN vs ARIMIDEX
ARGATROBAN vs ARIPIPRAZOLE
ARGATROBAN vs ARIPIPRAZOLE LAUROXIL